Ignite Creation Date:
2024-05-05 @ 11:26 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00047671
Status:
COMPLETED
Last Update Posted:
2009-08-04
First Post:
2002-10-11
Brief Title:
Ethnic Variations in Antidepressant Response
Sponsor:
National Institute of Mental Health NIMH
Organization:
National Institute of Mental Health NIMH
Study Overview
Official Title:
Ethnic Variations in Antidepressant Response
Status:
COMPLETED
Status Verified Date:
2009-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This 11-week study aims to determine how genetic factors affect the way African Americans and Caucasians with major depression respond to antidepressant medication citalopram Celexa
Detailed Description:
Depressed patients vary substantially in their responses to antidepressants Genetic factors may account for a large part of these differences in response This study will include both African Americans and Caucasians to examine the role of genetic factors in treatment response
Participants receive citalopram Celexa for 8 weeks and a placebo for 1 week Visits occur once a week for 11 weeks A variety of interviews scales tests and questionnaires are used to assess participants
Participants receive citalopram Celexa for 8 weeks and a placebo for 1 week Visits occur once a week for 11 weeks A variety of interviews scales tests and questionnaires are used to assess participants
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| DATR A5-ETMA | None | None | None |
| EVA-00183-02 | None | None | None |